Specialized Metrics To Properly Assess AI-Pharma Startups

Specialized Metrics To Properly Assess AI-Pharma Startups

Source: 
LinkedIn
snippet: 

The level of sophistication used in due diligence should be on a par with the level of complexity in a given industry. AI-Pharma companies are 100 times as complex as FinTech companies. Methodologies used to assess them should be 100 times as rigorous.